|
1
|
Mallat SG, Al Kattar S, Tanios BY and
Jurjus A: Hyperuricemia, Hypertension, and Chronic Kidney Disease:
An Emerging Association. Curr Hypertens Rep. 18:742016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Essex MN, Hopps M, Bienen EJ, Udall M,
Mardekian J and Makinson GT: Evaluation of the relationship between
serum uric acid levels and cardiovascular events in patients with
gout: A retrospective analysis using electronic medical record
data. J Clin Rheumatol. 23:160–166. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bos MJ, Koudstaal PJ, Hofman A, Witteman
JC and Breteler MM: Uric acid is a risk factor for myocardial
infarction and stroke: The Rotterdam study. Stroke. 37:1503–1507.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fang J and Alderman MH: Serum uric acid
and cardiovascular mortality the NHANES I epidemiologic follow-up
study, 1971–1992. National Health and Nutrition Examination Survey.
JAMA. 283:2404–2410. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ford ES, Li C, Cook S and Choi HK: Serum
concentrations of uric acid and the metabolic syndrome among US
children and adolescents. Circulation. 115:2526–2532. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lehto S, Niskanen L, Rönnemaa T and Laakso
M: Serum uric acid is a strong predictor of stroke in patients with
non-insulin-dependent diabetes mellitus. Stroke. 29:635–639. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li P, Zhang L, Zhang M, Zhou C and Lin N:
Uric acid enhances PKC-dependent eNOS phosphorylation and mediates
cellular ER stress: A mechanism for uric acid-induced endothelial
dysfunction. Int J Mol Med. 37:989–997. 2016.PubMed/NCBI
|
|
8
|
Cai W, Duan XM, Liu Y, Yu J, Tang YL, Liu
ZL, Jiang S, Zhang CP, Liu JY and Xu JX: Uric Acid Induces
Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling
Pathway. BioMed Res Int. 2017:43919202017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wong CK, Chen Y, Ho LM, Zhen Z, Siu CW,
Tse HF and Yiu KH: The effects of hyperuricaemia on flow-mediated
and nitroglycerin-mediated dilatation in high-risk patients. Nutr
Metab Cardiovasc Dis. 24:1012–1019. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Naka KK, Papathanassiou K, Bechlioulis A,
Kazakos N, Pappas K, Tigas S, Makriyiannis D, Tsatsoulis A and
Michalis LK: Determinants of vascular function in patients with
type 2 diabetes. Cardiovasc Diabetol. 11:1272012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Calvert JW: Cardioprotective effects of
nitrite during exercise. Cardiovasc Res. 89:499–506. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang R, Zhang Y, Xu L, Lin Y, Yang X, Bai
L, Chen Y, Zhao S, Fan J, Cheng X, et al: Protein Inhibitor of
Activated STAT3 Suppresses Oxidized LDL-induced Cell Responses
during Atherosclerosis in Apolipoprotein E-deficient Mice. Sci Rep.
6:367902016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Slanina H, Schmutzler M, Christodoulides
M, Kim KS and Schubert-Unkmeir A: Effective plasmid DNA and small
interfering RNA delivery to diseased human brain microvascular
endothelial cells. J Mol Microbiol Biotechnol. 22:245–257. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang D, Atlasi SS, Patel KK, Zhuang Z and
Heaney AP: False responses of Renilla luciferase reporter control
to nuclear receptor TR4. Mol Cell Biochem. 430:139–147. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ding XH, Wang X, Cao R, Yang X, Xiao W,
Zhang Y, Bai Y, Wu H and Ye P: A higher baseline plasma uric acid
level is an independent predictor of arterial stiffness: A
community-based prospective study. Medicine (Baltimore).
96:e59572017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Volterrani M, Iellamo F, Sposato B and
Romeo F: Uric acid lowering therapy in cardiovascular diseases. Int
J Cardiol. 213:20–22. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang J, Sun Y, Niu K, Wan Z, Yao W, Gao
Y, Zhang W, Li Y, Zhao H and Wu X: Does elevated serum uric acid
level predict the hypertension incidence? A Chinese prospective
cohort study. Clin Exp Hypertens. 37:498–504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang TY, Fang CY, Chen JS, Po HL, Chou LP,
Chiang CY and Ueng KC: Association of Serum Uric Acid with
Cardiovascular Disease in Taiwanese Patients with Primary
Hypertension. Acta Cardiol Sin. 31:42–51. 2015.PubMed/NCBI
|
|
19
|
McCarthy CG, Goulopoulou S, Wenceslau CF,
Spitler K, Matsumoto T and Webb RC: Toll-like receptors and
damage-associated molecular patterns: Novel links between
inflammation and hypertension. Am J Physiol Heart Circ Physiol.
306:H184–H196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Verdoia M, Barbieri L, Schaffer A,
Cassetti E, Nardin M, Bellomo G, Aimaretti G, Marino P, Sinigaglia
F and De Luca G: Novara Atherosclerosis Study Group (NAS): Impact
of diabetes on uric acid and its relationship with the extent of
coronary artery disease and platelet aggregation: A single-centre
cohort study. Metabolism. 63:640–646. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Borghi C and Desideri G: Urate-lowering
drugs and prevention of cardiovascular disease: The emerging role
of xanthine oxidase inhibition. Hypertension. 67:496–498.
2016.PubMed/NCBI
|
|
22
|
Kaneko C, Ogura J, Sasaki S, Okamoto K,
Kobayashi M, Kuwayama K, Narumi K and Iseki K: Fructose suppresses
uric acid excretion to the intestinal lumen as a result of the
induction of oxidative stress by NADPH oxidase activation. Biochim
Biophys Acta. 1861:559–566. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Spiga R, Marini MA, Mancuso E, Di Fatta C,
Fuoco A, Perticone F, Andreozzi F, Mannino GC and Sesti G: Uric
acid is associated with inflammatory biomarkers and induces
inflammation via activating the NF-κB Signaling Pathway in HepG2
Cells. Arterioscler Thromb Vasc Biol. 37:1241–1249. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo C, Lian X, Hong L, Zou J, Li Z, Zhu Y,
Huang T, Zhang Y, Hu Y, Yuan H, et al: High Uric Acid Activates the
ROS-AMPK Pathway, Impairs CD68 Expression and Inhibits
OxLDL-Induced Foam-Cell Formation in a Human Monocytic Cell Line,
THP-1. Cell Physiol Biochem. 40:538–548. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee KS, Kim J, Kwak SN, Lee KS, Lee DK, Ha
KS, Won MH, Jeoung D, Lee H, Kwon YG, et al: Functional role of
NF-κB in expression of human endothelial nitric oxide synthase.
Biochem Biophys Res Commun. 448:101–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grumbach IM, Chen W, Mertens SA and
Harrison DG: A negative feedback mechanism involving nitric oxide
and nuclear factor kappa-B modulates endothelial nitric oxide
synthase transcription. J Mol Cell Cardiol. 39:595–603. 2005.
View Article : Google Scholar : PubMed/NCBI
|
